Advertisement
Canada markets close in 3 hours 56 minutes
  • S&P/TSX

    22,338.30
    +78.83 (+0.35%)
     
  • S&P 500

    5,195.05
    +14.31 (+0.28%)
     
  • DOW

    38,911.09
    +58.82 (+0.15%)
     
  • CAD/USD

    0.7294
    -0.0027 (-0.36%)
     
  • CRUDE OIL

    78.30
    -0.18 (-0.23%)
     
  • Bitcoin CAD

    87,422.80
    +214.36 (+0.25%)
     
  • CMC Crypto 200

    1,321.48
    -43.65 (-3.20%)
     
  • GOLD FUTURES

    2,321.60
    -9.60 (-0.41%)
     
  • RUSSELL 2000

    2,077.00
    +16.32 (+0.79%)
     
  • 10-Yr Bond

    4.4230
    -0.0660 (-1.47%)
     
  • NASDAQ

    16,385.67
    +36.42 (+0.22%)
     
  • VOLATILITY

    13.47
    -0.02 (-0.15%)
     
  • FTSE

    8,313.67
    +100.18 (+1.22%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6770
    -0.0022 (-0.32%)
     

Medifast, Inc. (MED) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Medifast, Inc. (MED). The stock has moved higher by 24.1% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider MED’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as MED has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All                

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

ADVERTISEMENT

See Zacks' 3 Best Stocks to Play This Trend >>

 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MEDIFAST INC (MED) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research